Evidence map›Paper›PMID 33278399›Full record

SynthesisThe Journal of infection2021

Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review.

Lara Marleen Fricke, Stephan Glöckner, Maren Dreier, Berit Lange

Abstract readSystematic Review
In one paragraph

Synthesis in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Lara Marleen FrickeHelmholtz Centre for Infection Research (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany; Hannover Medical School (MHH), Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Electronic address: fricke.lara@mh-hannover.de.
Stephan GlöcknerHelmholtz Centre for Infection Research (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany; German Center for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany. Electronic address: stephan.gloeckner@helmholtz-hzi.de.
Maren DreierHannover Medical School (MHH), Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Electronic address: dreier.maren@mh-hannover.de.
Berit LangeHelmholtz Centre for Infection Research (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany; German Center for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany. Electronic address: berit.lange@helmholtz-hzi.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo better understand the impact of comprehensive COVID-19 targeted non-pharmaceutical interventions (NPIs) on influenza burden worldwide.

methodsWe conducted a systematic literature search in selected databases (PubMed, WHO COVID-19), preprint servers (medRxiv, bioRxiv) and websites of European Public Health institutes. Documents that compared influenza estimates in the 2019/2020 season with previous seasons were included. Information synthesis was qualitative due to a high heterogeneity in the number and periods of comparative seasons, outcome measures and statistical methods.

resultsWe included 23 records reporting from 15 countries/regions as well as 8 reports from European Public Health agencies. Estimates in the 2019/2020 season based on influenza virus tests (4 out of 7 countries/regions), defined influenza cases (8 out of 9), influenza positivity rate (7 out of 8), and severe complications (1 out of 2) were lower than in former seasons. Results from syndromic indicators, such as influenza-like-illness (ILI), were less clear or even raised (4 out of 7) after the influenza season indicating a misclassification with COVID-19 cases.

conclusionsEvidence synthesis suggests that NPIs targeted at SARS-CoV-2-transmission reduce influenza burden as well. Low threshold NPIs need to be more strongly emphasized in influenza prevention strategies.

Indexed as

Hand DisinfectionPhysical DistancingContact TracingCOVID-19COVID-19 TestingHumansInfluenza, HumanRespiratory Protective DevicesSARS-CoV-2COVID-19FluInfluenzaNon-pharmaceutical interventionsSARS-CoV-2SurveillanceSystematic review

Identifiers

PMID33278399
PMCPMC9183207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.